EMERGEX VACCINES HOLDING LTD has a total of 34 patent applications. Its first patent ever was published in 2015. It filed its patents most often in United States, Brazil and Singapore. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are VARIATION BIOTECHNOLOGIES INC, SERUM INSTITUTE OF INDIA PRIVATE LTD and EMERGEX VACCINES HOLDINGS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Brazil | 5 | |
#3 | Singapore | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 5 | |
#5 | Australia | 4 | |
#6 | China | 2 | |
#7 | Philippines | 2 | |
#8 | Canada | 1 | |
#9 | United Kingdom | 1 | |
#10 | Israel | 1 | |
#11 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Climate change adaptation technologies | |
#6 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Philip Ramila | 26 |
#2 | Rademacher Thomas | 10 |
#3 | Ramila Philip | 7 |
#4 | Rademacher Laurens | 6 |
#5 | Huang Xiaofang | 4 |
#6 | Upton Christopher | 4 |
#7 | Thomas Rademacher | 3 |
#8 | Perrins Dr Richard David | 2 |
#9 | Xiaofang Huang | 2 |
#10 | Christopher Upton | 2 |
Publication | Filing date | Title |
---|---|---|
AU2019270582A1 | Reverse peptide vaccine | |
WO2019186200A1 | Vaccine compositions | |
CN112292148A | Vaccine composition | |
AU2019205627A1 | MHC class I associated peptides for prevention and treatment of multiple flavi virus | |
GB201820614D0 | MHC Class I associated peptides for prevention and treatment of hepatitis B virus infection | |
US2020101150A1 | Dengue Virus Specific Multiple HLA Binding T Cell Epitopes For The Use Of Universal Vaccine Development | |
BR112020005565A2 | class i mhc-associated peptides for prevention and treatment of zika virus | |
SG11201906190YA | Universal influenza vaccine compositions |